Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Global biotechnology company Clinical Data has launched its pain research genotyping service by its Cogenics Division.
Subscribe to our email newsletter
Cogenics developed the proprietary genotyping service called the Pain Research Panel, which enables the investigation of key target genes involved in pain as well as those that mediate the therapeutic effects of pharmacological agents used to treat pain, inflammation, and mood conditions.
The panel is based on a custom Affymetrix microarray made available through an agreement with Algynomics Inc and contains more than 3,000 SNPs representing 350 genes implicated in pain perception, inflammation, and mood.
William Maixner, president of Algynomics, said: “We have designed the Pain Research Panel for use in research studies seeking to identify the genetic contribution to pain susceptibility and to examine positive and adverse responses to therapeutic regimens for acute and chronic pain.”